ArticleJournal of the anus, rectum and colon2026
Short-term Outcomes of Sacral Neuromodulation for Fecal Incontinence and the Predictive Role of Test Stimulation.
Article in Journal of the anus, rectum and colon, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate short-term outcomes of sacral neuromodulation (SNM) for fecal incontinence (FI) in a Japanese clinical setting, and to assess the predictive value of response during the test stimulation phase. Methods: We retrospectively evaluated patients with FI who underwent SNM between 2014 and 2024. Patients proceeded to permanent implantation following a 2-week test stimulation. Primary outcomes included changes in weekly FI episodes, Cleveland Clinic Florida Fecal Incontinence Score (CCFIS), Fecal Incontinence Severity Index (FISI), and Japanese Fecal Incontinence Quality of Life Scale (JFIQL). Anorectal manometry data were also assessed. A receiver operating characteristic (ROC) curve was constructed to investigate the predictive utility of test-phase response. Results: Of 34 patients, 32 (94.1%) proceeded to implantation. Two subsequently required explantation, and 30 completed the 12-month follow-up. At 12 months, median weekly FI episodes decreased from 7.5 to 3.0, CCFIS from 15.0 to 9.0, and FISI from 36.5 to 22.5; JFIQL improved from 2.02 to 2.53 (all p < 0.05). A ≥50% reduction in FI episodes was achieved in 20 of 30 patients (66.7%). Maximum squeezing pressure significantly increased from 90.0 to 107.0 mmHg (p = 0.013), while maximum resting pressure did not change significantly. ROC analysis yielded an area under the curve (AUC) of 0.663, identifying a 36.4% reduction in FI episodes during the test phase. Conclusions: SNM demonstrated favorable short-term outcomes in Japanese patients with FI, including improved continence, quality of life, and anal sphincter function. Early partial response during the test phase may serve as a useful predictor of sustained benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.